Patient satisfaction high with PanOptix trifocal IOL
Click Here to Manage Email Alerts
KOLOA, Hawaii — Patients who received the newly approved PanOptix trifocal lens reported high levels of satisfaction with the technology, according to a speaker here.
A data analysis of all PanOptix (Alcon) patients of two surgeons was completed using both objective and subjective measurements, Sheri Rowen, MD, said at Hawaiian Eye 2020. Patients, including post-LASIK patients, were examined for distance, near and intermediate vision and completed surveys regarding halos, glare, need for glasses, quality of vision and happiness.
In the post-LASIK population, which totaled 36% of the study, 79% had 20/30 vision or better at 1 week, with 95% 20/25 or better with correction.
At 1 to 3 months, 93% remained 20/40 or better and 85% were correctable to 20/25 or better.
In the monocular patient population, 72% were 20/20 or greater.
“The 1 to 3 months postop monocular uncorrected intermediate was really a wow factor,” Rowen said. “We had really good visual acuity results, so next we wanted to find out how the patients like it.”
In subjective patient surveys, 68.2% reported no halos or mild halos, with 30.8% reporting moderate to severe halos. Twenty-one percent reported using glasses for near tasks, while 79% reported no glasses use.
Fifty percent reported a 10-out-of-10 happiness level, with 86% marking a level between 8 and 10.
“So, what happened in that 8 to 10? There was a little contrast issue,” Rowen said. “They don’t perceive it being as perfect or sharp as they might like it. If someone says they’re foggy or hazy, that is where you’re going to have a low happiness score.”
The majority of patients did not experience halos, and those who did were mostly mild and non-debilitating. Ninety-five percent of patients reported they would have the same lens implanted again.
“Patients are pretty overjoyed with PanOptix trifocal IOL for function and quality of vision,” Rowen said. – by Rebecca L. Forand
Reference:
Rowen S. Early results of the recent FDA approved trifocal lens. Presented at: Hawaiian Eye 2020; Jan. 18-24, 2020; Koloa, Hawaii.
Disclosure: Rowen reports she is a consultant to Alcon.